(Q28142633)

https://api.crossref.org/works/10.1177%2F026988119901300111

Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

FATAL HYPERPYREXIA WITH ANTIDEPRESSANT DRUGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Pathophysiology and management of the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants: II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The biochemical, behavioral, and neurologic effects of high Ltryptophan intake in the rhesus monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Amphetamine poisoning. Effectiveness of chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The role of 5-hydroxytryptamine and noradrenaline in the hyperthermic reaction induced by pethidine in rabbits pretreated with pargyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Cumulative effects of irreversible MAO inhibitors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Neuroleptic influence on hyperthermia induced by 5-hydroxytryptophan and p-methoxy-amphetamine in MAOI-pretreated rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Possible serotonin syndrome with trazodone addition to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Combined Tricyclic-MAOI Therapy for Refractory Depression: A Review, with Guidelines for Appropriate Usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Sertraline-phenelzine drug interaction: a serotonin syndrome reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Interaction of fluoxetine and pentazocine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Heat-stroke: a review of rapid cooling techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Serotonin syndrome induced by administration of venlafaxine and phenelzine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Serotonin syndrome and drug combinations: focus on MAOI and RIMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Possible development of the serotonin syndrome in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Toxic interaction of venlafaxine and isocarboxazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Interactions between relatively selective monoamine oxidase inhibitors and an inhibitor of 5-hydroxytryptamine re-uptake, clomipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The central nervous system serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Drug-induced hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Sustained Plasma Concentrations of Fluoxetine and/or Norfluoxetine Four and Eight Weeks After Fluoxetine Discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Hyperpyrexia following psychotropic drug overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Comparison of the effects of morphine, pethidine and pentazocine in rabbits pretreated with a monoamine oxidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Fluoxetine and the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Tricyclic Antidepressants and Monoamine Oxidase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

A Study of Refractory Cases of Depressive Illnesses and their Response to Combined Antidepressant Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

The serotonin syndrome. Implicated drugs, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Severe adverse interaction between pethidine and selegiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111

Catastrophic Illness Associated with the Combination of Clomipramine, Phenelzine, and Chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300111